Brought to you by 
Pfizer buys NextWave for $255mm in cash plus up to $425mm in earn-outs
24 Sep 2020
Executive Summary
Pfizer Inc. is exercising its option to acquire private specialty pharmaco NextWave Pharmaceuticals Inc. The Big Pharma will pay $255mm in cash up front, plus up to $425mm in sales-based earn-outs.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pfizer buys NextWave for $255mm in cash plus up to $425mm in earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice